- Fee assured
- Verified account
- Open Referral network
Specialises in
- Endoscopy
- Inflammatory bowel disease
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Pavlidis is a Consultant Gastroenterologist and Physician based at King's College Hospital in London and he also sees patients privately at Kings Private, the HCA The Shard and The London Bridge Hospital. Following his medical degree (University of Thessaly, Larissa, Greece, 2006) he undertook post-graduate training in London, working at internationally renowned centres of excellence including Kings College Hospital and Guys and St Thomas NHS Foundation Trusts. Dr Pavlidis holds a PhD in Transplantation Immunology and Mucosal Biology from Kings College London (2018). He was the NIHR Academic Clinical Lecturer in Gastroenterology at Kings Health Partners from 2018 to 2021.
His clinical expertise lies in providing a holistic and personalised approach for patients with acute and chronic gastrointestinal symptoms or diseases. His subspecialty interests include conditions that may result from the interaction of the gut-brain- microbiome axis (like irritable bowel syndrome), immune mediated inflammatory bowel diseases (ulcerative colitis, Crohn disease) or following chemotherapy/immunotherapy/stem cell transplantation for cancer (graft versus host disease, checkpoint inhibitor colitis).
Dr Pavlidis is a JAG accredited endoscopist for upper and lower GI diagnostic and therapeutic procedures. He has also been accredited to contribute to the national bowel cancer screening programme (colonoscopy).As a core member of the IBD team at Kings he provides surveillance colonoscopy for patients at high risk of colorectal cancer, including those with a long diagnosis of ulcerative colitis and people with combined liver and gut inflammation like PSC-IBD.
As the Upper GI Cancer, Two-Week-Wait pathway Lead at Kings he aspires to deliver with his team a high quality, rapid diagnostics service for patients presenting with concerning gastrointestinal symptoms. As the Clinical Governance Lead his priority is to lead the wider luminal gastroenterology teams efforts in providing safe and evidenced base care with empathy, personalised to the individual's needs.
Polychronis leads an ambitious translational research programme funded by major national funding streams (NIHR, MRC), charities (CCUK, Guts UK) and other stakeholders aiming to deliver stratified medicine approaches in chronic gut inflammation as well as inform evidence-based practice. He has presented his research work at national and international fora receiving multiple awards and published in high impact journals like Nature Communications, Cell Reports and Gut. He has co-authored leading national and international guidelines as well as consensus statements on the management of IBD, personalised medicine approaches and checkpoint inhibitor induced colitis.
Areas of interest
Conditions: Inflammatory bowel diseases (Crohn's disease, ulcerative colitis, microscopic colitis, eosinophilic oesophagitis); irritable bowel syndrome; bowel cancer screening
GI symptoms: acid reflux, indigestion, dyspepsia, abdominal pain and bloating, change in bowel habit
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X3510
IV sedation administered by operator - (5-50)
London Bridge Hospital (5-50)
-
G6500
Diagnostic oesophago-gastro-duodenoscopy (OGD) includes forceps biopsy, biopsy urease test and dye spray - (5-50)
London Bridge Hospital (5-50)
-
H2002
Diagnostic colonoscopy, includes forceps biopsy of colon and ileum - (1-5)
London Bridge Hospital (1-5)
-
H2003
Therapeutic colonoscopy with snare loop biopsy or excision of lesion - (1-5)
London Bridge Hospital (1-5)
-
G8082
Diagnostic oesophago-gastro-duodenoscopy (OGD) and immediate colonoscopy includes forceps biopsies, biopsy test and dye spray (as sole procedure) - (1-5)
London Bridge Hospital (1-5)
- Show All (6 )...